COVID-19 and Supplement Sales Update: Examining Market Data and Attitudes as Consumers Continue Their Wellness Journeys – webinarCOVID-19 and Supplement Sales Update: Examining Market Data and Attitudes as Consumers Continue Their Wellness Journeys – webinar
Now available on-demand
May 26, 2020
Date: Jul 28, 2023
Sponsored by Council for Responsible Nutrition
Special group discount: Buy one registration, get five free for your company colleagues. To take advantage of this, paid registrations will receive an email confirmation (check your spam folder, if not received) with the code to pass on to colleagues.
COST: $299 - CRN Members receive a $100 discount by using code: CRN100. Non-members using this code will be charged the additional amount. Add to safe sender list for receipt and confirmation via email: webmaste[email protected] and [email protected].
Building on our April webinar where we learned about the COVID-19 supplement sales spike—including consumer attitudes and data on which categories saw the most increases—we’ll take another look at whether these increases are sustained as consumers adjust to the “new normal.” Can the surge continue as the industry strives to deliver the wellness support consumers are seeking? Is the immediate consumer response to COVID-19 when it comes to self-care transforming lifestyles with longer-term habits, growing the base of wellness warriors?
Brian Wommack, Senior Vice President, Communications, Council for Responsible Nutrition
Raj Sapru, COO, Netrush
Kristin Hornberger, Executive, Healthcare, IRI Worldwide
Steve French, Managing Partner, Natural Marketing Institute
Kathryn Peters, Executive Vice President, Business Development, SPINS
Colleague promo code is now CRNStaff.
You May Also Like
Beyond vaginal microbiota: Emotional well-being, gut health support – white paperNov 22, 2023
Unrivaled performance: Game-changing nutrition for athletes – infographicNov 30, 2023
Sabinsa’s new study on ashwagandha ingredient adds to botanical’s stress relief storDec 05, 2023
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023